Al Jazeera2/7/2026Salud4 min de lectura
UK-US Pharmaceutical Deal Could Lead to 229,000 Excess Deaths, Study Warns
Research in BMJ highlights potential consequences of diverting NHS funds to US medicines
En resumen
A UK-US pharmaceutical trade deal may cause 229,000 excess deaths in the UK by 2036 due to diverted NHS funding, according to BMJ research, as billions are allocated to US medicines with no additional NHS funding
Resumen generado por IA
Tamaño de fuente
Research published in the British Medical Journal (BMJ) has found that a United Kingdom-United States pharmaceutical deal could cause 229,000 excess deaths as a result of the diversion of billions of pounds away from Britain’s National Health Service (NHS)... (full article text preserved with paragraph breaks)
Temas relacionados
This article was originally published by Al Jazeera.
